National Vaccine Injury Compensation Program: Statement of Reasons for Not

Similar documents
Updating the Vaccine Injury Table: Legal and Policy Considerations. Elizabeth H. Saindon Senior Attorney Office of the General Counsel, HHS

The National Vaccine Injury Compensation Program (VICP) MMR Vaccine and Diabetes Mellitus

Anaphylaxis: A Life Threatening Allergic Reaction

Guidance for Industry

VACCINE INJURY COMPENSATION. Most Claims Took Multiple Years and Many Were Settled through Negotiation

Anaphylaxis. Exceptional healthcare, personally delivered

7. Laws IN THIS SECTION INTRODUCTION

Glossary of Terms. Section Glossary. of Terms

Food Allergies. Food Allergy statistics: True Prevalence of Food Allergy

Food allergy /anaphylaxis

What You Need to Know About the National Vaccine Injury Compensation Program (VICP)

John M. Kelso, MD, James T. Li, MD, PhD, and Matthew J. Greenhawt, MD, MBA

This annual data report demonstrates findings consistent with previous reports:

R 5331 MANAGEMENT OF LIFE-THREATENING ALLERGIES IN SCHOOLS

Title 14 of the Code of Federal Regulations (14 CFR) part 121, subpart N and subpart X.

Immunology, J Allergy Clinical Immunology 1998; Vol.102, No. 2,

Proposed Vaccine Information Materials for HPV (Human. AGENCY: Centers for Disease Control and Prevention (CDC),

Updating the Vaccine Injury Table: Guillain-Barré Syndrome (GBS) and Seasonal Influenza Vaccines

Food Allergies and. Food allergies and the immune system. Food allergies and the immune system

BSTA Anaphylaxis /Stock Epinephrine Policy

Appendix D APPENDIX D Vaccine Safety

Allergies: ENT and Allergy Center of Missouri YOUR GUIDE TO TESTING AND TREATMENT. University of Missouri Health Care

Influenza Vaccine Protocol Agreement (O.C.G.A. Section )

Name of Policy: Antigen Leukocyte Cellular Antibody Test (ALCAT)

Document issued on: December 2, The draft of this document was issued on March 11, Contains Nonbinding Recommendations

Lesson 3 Managing Food Allergies

Anaphylaxis and other adverse events

The percentage of people with food allergy in the community

llergy Testing: When to test, when not to and what to do with the results

Sample Rhode Island School Food Allergy Policy

William E. Berger, M.D., M.B.A. Clinical Professor Department of Pediatrics Division of Allergy and Immunology University of California, Irvine

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration. Advisory Council on Blood Stem Cell Transplantation

Vaccine Protocol Agreement. Name of Pharmacy: Address: City, State, Zip:

Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL Phone (813) , Fax (813)

Anaphylaxis Management. Pic 1 Severe allergic reaction which led to anaphylaxis

GAO. VACCINE INJURY COMPENSATION Program Challenged to Settle Claims Quickly and Easily

Food Allergies and Epinephrine in Schools

Step 6: Documenting and Related Issues

Warroad Public Schools Allergy/Anaphylaxis Management Guidelines

Anaphylaxis & Administration Of Stock Epinephrine. Training for Michigan Schools. From: Michigan Association of School Nurses

Guidance for Industry

ADMINISTRATION OF DRUG PRODUCTS/MEDICATIONS TO STUDENTS

A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy.

Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions

Emergency Anaphylaxis Management: Opportunities for Improvement. Ronna Campbell, MD, PhD August 31, 2015

The Diagnosis of Food Allergy

Data & Statistics What does it mean to be awarded compensation? What reasons might a claim result in a negotiated settlement?

Agreements and Memoranda of Understanding Between the Food and Drug Administration and

How to Submit a School Epinephrine Report

In those instances, the National Vaccine Injury Compensation Program (VICP) allows individuals to file a petition for compensation.

Animal dander: Such as the hair and secretions of pets like cats and dogs.

FINAL GUIDANCE. For questions on the content of this guidance, contact Advisory Committee Oversight and Management Staff, at

Food Allergies In Our Schools

Food Allergy Diagnosis and Management in the United States

Anaphylaxis before and after the emergency

Annual Epinephrine Training Program for Connecticut s Unlicensed School Personnel

Allergy Testing Test Request and Result Interpretation. Learning Objectives

Food Allergen Fundamentals

NATIONAL VACCINE INJURY COMPENSATION PROGRAM

Schools + School Nurses = Safe and Healthy Students. Presenter s Guide

See, Think, and Act! Anaphylaxis (Severe Allergies)

IgE-mediated Food Allergies

TITLE II FOOD ALLERGEN LABELING AND CONSUMER PROTECTION

Food Allergen Management Training

YORK REGION DISTRICT SCHOOL BOARD. Policy and Procedure #661.0, Anaphylactic Reactions

Update on Anaphylaxis: Recognition and Treatment in a College Health Service. Eleanor W Davidson MD Sara H Lee MD February

ENSURING STABLE AND CONTINUOUS HEALTH INSURANCE COVERAGE FOR CHILDREN WITH ASTHMA

MINISTRY OF HEALTH PANDEMIC INFLUENZA A / H1N VACCINE FREQUENTLY ASKED QUESTIONS

MEDICATION MANUAL Policy & Procedure

Safety of HPV vaccination: A FIGO STATEMENT

Selective IgA deficiency (slgad)

H1N1 Flu Vaccine Available to All Virginia Beach City Public Schools Students

Important Information About the Side-Effects of Invokana

Frequently Asked Questions about Crab Asthma

Guidelines for the Management of Children with Peanut or Tree Nut Allergies in the School Setting

How To Plan Healthy People 2020

SCHOOL RESOURCES. For CHRONIC DISEASE MANAGEMENT

Section I New Policy with copy of updated Epipen Order, and protocol. Section II Anaphylaxis Management Algorithm

Guidance for Industry Independent Consultants for Biotechnology Clinical Trial Protocols

Anaphylaxis - severe allergic reaction

FAQs on Influenza A (H1N1-2009) Vaccine

Allergy Shots and Allergy Drops for Adults and Children. A Review of the Research

Allergy Testing Clinical Coverage Policy No: 1N-1 Amended Date: October 1, Table of Contents

Wyckoff Administration Policy on Epinephrine Nurse, Student and or Delegate

Name Date Class. This section explains what kinds of organisms cause infectious disease and how infectious diseases are spread.

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

St Mark s Anglican Community School

Adrenaline autoinjector (EpiPen) for acute allergic anaphylaxis

In the United States Court of Federal Claims

Managing Life-Threatening Allergies in School. Prepared by the Hanover Public Schools Health Services Department March 18, 2010

APPENDIX I-A: INFORMED CONSENT BB IND Protocol CDC IRB #4167

PARENT/GUARDIAN REQUEST: ADMINISTRATION OF EMERGENCY EPINEPHRINE, ANAPHYLAXIS CARE PLAN/ IHP & IEHP

Chapter 3. Immunity and how vaccines work

NC General Statutes - Chapter 143 Article 56 1

DEPARTMENT OF LABOR. Office of Workers Compensation Programs. Division of Federal Employees Compensation

Students 4000 OP Anaphylaxis in Schools

IMPORTANT: PLEASE READ

100% WHEY PROTEIN PARTIALLY HYDROLYZED in Infant Formula and REDUCING THE RISK OF ALLERGY IN INFANTS EXECUTIVE SUMMARY

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products

Transcription:

This document is scheduled to be published in the Federal Register on 03/29/2016 and available online at http://federalregister.gov/a/2016-06666, and on FDsys.gov Billing Code: 4165-15 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration 42 CFR Part 100 National Vaccine Injury Compensation Program: Statement of Reasons for Not Conducting Rulemaking Proceedings AGENCY: Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Denial of petition for rulemaking. SUMMARY: In accordance with section 2114(c)(2)(B) of the Public Health Service Act, 42 U.S.C. 300aa-14(c)(2)(B), notice is hereby given concerning the reasons for not conducting rulemaking proceedings to add food allergies as an injury associated with vaccines to the Vaccine Injury Table. DATES: Written comments are not being solicited. FOR FURTHER INFORMATION CONTACT: Dr. Narayan Nair, MD, Acting Director, Division of Injury Compensation Programs (DICP), Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 8N146B Rockville, Maryland 20857, or by telephone 301-443-6593. SUPPLEMENTARY INFORMATION: The National Childhood Vaccine Injury Act of 1986, Title III of Public Law 99-660 (42 U.S.C. 300 aa- 10 et seq.) established the National Vaccine Injury Compensation Program (VICP) for persons found to be injured by vaccines. Under this federal program, petitions for compensation are filed with the United States Court of Federal Claims (Court). The Court, acting through special masters, makes findings as to eligibility for, 1

and amount of, compensation. In order to gain entitlement to compensation under the VICP for a covered vaccine, a petitioner must establish a vaccine-related injury or death, either by proving that the first symptom of an injury or condition, as defined by the Qualifications and Aids to Interpretation, occurred within the time period listed on the Vaccine Injury Table (Table), and therefore, is presumed to be caused by a vaccine (unless another cause is found), or by proof of vaccine causation, if the injury or condition is not on the Table or did not occur within the time period specified on the Table. The statute authorizing the VICP provides for the inclusion of additional vaccines in the VICP when they are recommended by the Centers for Disease Control and Prevention (CDC) for routine administration to children. See section 2114(e)(2) of the PHS Act, 42 U.S.C. 300aa- 14(e)(2). Consistent with section 13632(a)(3) of Public Law 103-66, the regulations governing the VICP provide that such vaccines will be included in the Table as of the effective date of an excise tax to provide funds for the payment of compensation with respect to such vaccines. 42 CFR 100.3(c)(8). The statute authorizing the VICP also authorizes the Secretary to create and modify a list of injuries, disabilities, illnesses, conditions, and deaths (and their associated time frames) associated with each category of vaccines included on the Table. See sections 2114(c) and 2114(e)(2) of the PHS Act, 42 U.S.C. 300aa- 14(c) and 30aa-14(e)(2). Finally, section 2114(c)(2) of the PHS Act, 42 U.S.C. 300aa- 14(c)(2) provides that: [a]ny person (including the Advisory Commission on Childhood Vaccines) [the Commission] may petition the Secretary to propose regulations to amend the Vaccine Injury Table. Unless clearly frivolous, or initiated by the Commission, any such petition shall be referred to the Commission for its recommendations. Following (A) Receipt of any recommendation of the Commission, or 2

(B) 180 days after the date of the referral to the Commission, whichever occurs first, the Secretary shall conduct a rule-making proceeding on the matters proposed in the petition or publish in the Federal Register a statement or reasons for not conducting such proceeding. On September 19, 2015, a private citizen submitted an email to the Department of Health and Human Services (HHS) and the Commission, requesting that food allergies be added to the Table. The email was considered to be a petition to the Secretary of HHS to propose regulations to amend the Table to add food allergies as an injury associated with vaccines on the Table. In support of the request that food allergies be added to the Table, the petitioner asserts that food proteins present in vaccines cause the development of food allergies. Pursuant to the VICP statute, the petition was referred to the Commission on December 3, 2015. The Commission voted unanimously to recommend that the Secretary not proceed with rulemaking to amend the Table as requested in the petition. Food allergies are defined as an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. 1 Food allergy reactions are generally classified as mediated through immunoglobulin E (IgE), not mediated through IgE, or involving both IgE and non-ige mechanisms. Food allergies are thought to result from a failure of the regulatory mechanisms of the immune system. IgE mediated reactions cause the severe and rapid responses to food known as anaphylaxis. Non-IgE mediated reactions cause slower onset skin and gastrointestinal symptoms. When a food allergy occurs, the body s immune system reacts to a food as if it was a threat. When people are first exposed to a potential food allergen, they do not experience 1 Boyce et al, Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAIDsponsored expert panel report. J Allergy Clin Immunol, Volume 16, Number 6,S1-58. 3

symptoms but, in some people, their immune system produces IgE to that food allergen. The production of IgE in response to an allergen is called sensitization. It is thought that sensitization can occur from exposure to the food through the skin and respiratory route, as well as from eating food allergens. When sensitized people are exposed to the food allergen again, the IgE antibodies may bind to the allergen, resulting in a release of chemicals which can trigger a severe allergic response. The symptoms of this response can include hives, itching, nausea, vomiting, swelling of the mouth and throat, difficulty breathing, and low blood pressure. 2 Not all people who have IgE to a food will have an allergic response. To support the claim that food allergies are caused by vaccines, the petitioner cites two sources as evidence including the 2012 Institute of Medicine (IOM) Report, Adverse Effects of Vaccines: Evidence and Causality. The 2012 IOM report reviewed 8 of the 12 vaccines covered by the VICP and provided 158 causality conclusions. However, the IOM report did not evaluate evidence regarding a causal association between vaccinations and food allergies. The report does describe case reports of individuals with a history of allergies to eggs, lamb, or milk that experienced anaphylaxis or an allergic reaction after receiving an immunization. 3 The IOM report does not address whether individuals who receive a vaccination may subsequently develop food allergies. This report does not comment on the strength of the epidemiologic or mechanistic evidence regarding food allergies and vaccination. Therefore, the 2012 IOM report does not support the petitioner s position for adding food allergies to the Table. The petition also describes a 2002 paper that appeared in the journal, Pediatrics. 4 The authors of this paper included researchers from CDC, the Food and Drug Administration (FDA), 2 http://www.niaid.nih.gov/topics/foodallergy/understanding/pages/allergicrxn.aspx 3 IOM (Institute of Medicine). 2012. Adverse effects of vaccines: Evidence and causality. Washington, DC: The National Academies Press. pp 170-173. 4 V. Pool, et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States, Pediatrics, 110, 6 (Dec. 2002): e71. 4

and the Mayo Clinic. The objective of this study was not to evaluate whether vaccines could cause food allergies. Rather, the purpose of the study was to examine whether people with anaphylaxis after the receipt of the measles vaccines had an unusual profile of self-reported allergies and whether they had higher levels of antibodies to gelatin, a compound found in both foods and some vaccines. This was a case control study utilizing the Vaccine Adverse Event Reporting System (VAERS) database for cases of anaphylaxis and individuals from the Mayo Clinic and VAERS who did not have an adverse event to the measles vaccine as controls. The study had relatively small numbers as only 57 individuals who had anaphylaxis agreed to be interviewed and of these, only 22 underwent IgE testing. The researchers found that there was a higher proportion of food allergies found in the group with anaphylaxis as opposed to the control group. However, it was not clear if the food allergies preceded the vaccine. They also noted that a number of individuals who had anaphylaxis to the vaccine also had the IgE antibody to the gelatin. However, none of these individuals reported an allergy to gelatin. This paper is not supportive of adding food allergies to the Table for several reasons. First, it was not designed to determine the causality of food allergy but rather whether severe allergic reactions to the measles vaccines could be due to gelatin. Gelatin is present in numerous foods including confectionary products, icings and fillings in baked goods, meat products, wine, beer, and juices. 5 Given that oral intake is not necessary for sensitization, a wide array of exposures could have led to the development of a food allergy. Second, the individuals in this study who had anaphylaxis to the measles vaccine and had antibodies to gelatin did not report a food allergy. This finding does not support a causal association between vaccines and food allergies, nor do the authors contend this in their study. Third, while there was a higher proportion of food allergies reported in the anaphylaxis group, the authors state the practical 5 http://www.gelatin-gmia.com/images/gmia_gelatin_manual_2012.pdf 5

significance of this is not clear. They conclude that their data could support the hypothesis that anaphylaxis to the measles vaccine could be due to sensitivity to gelatin but they do not assert that vaccines cause or contribute to food allergies. Finally, there are limitations to VAERS, which is a passive reporting system, and the primary purpose of VAERS is to look for signals for evidence of unexpected adverse events that would require other investigations to try to determine causal relationships. Thus, most VAERS reports alone cannot be utilized to establish conclusions about causality. In addition to reviewing evidence submitted by the petitioner, HHS gathered additional data from the existing medical literature. A literature search was conducted of the major medical databases for any articles linking the development of food allergies to vaccinations. This research was conducted in collaboration with the National Institutes of Health (NIH) Library, Office of Research Services. Despite an extensive search, no published research was found that addressed any linkages or potential causality between vaccinations covered by VICP and the development of food allergies in any population. While none of the publications identified a link between food allergies and vaccines, several did address risk factors related to the development of food allergies. The NIH National Institute of Allergy and Infectious Disease sponsored an expert panel to develop guidelines for the diagnosis and management of food allergies. This panel consisted of 34 professional organizations, federal agencies and patient advocacy groups all with expertise related to food allergies. The guidelines, which were published in 2010, discuss prevention of food allergies but make no mention of the role of vaccines in developing food allergies. They also do not list vaccination as a risk factor for developing food-induced anaphylaxis. The Guidelines discuss gaps in the scientific knowledge related to food allergies. However, they did not identify the role 6

of vaccination in developing food allergies as an area where future research is needed. 6 Several recent reviews of the epidemiology and natural history of food allergies have been published. None of the publications discuss any role of vaccinations in the development of food allergies. 7, 8, 9, 10, 11, 12 In light of the above, I have determined that there is no reliable scientific evidence of an association between vaccines and food allergies. Therefore, I will not amend the Table to add food allergies as an injury associated with any vaccine on the Table at this time. Dated: _March 17, 2016. Sylvia M. Burwell, Secretary, Department of Health and Human Services. 6 Boyce et al, Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol, Volume 16, Number 6,S1-58. 7 Lack, G. (2012). Update on risk factors for food allergy. Journal of Allergy and Clinical Immunology 129(5): 1187-1197. 8 Savage, J. and C. B. Johns. (2015). Food allergy: epidemiology and natural history. Immunol Allergy Clin North Am 35(1): 45-59. 9 Sicherer, S. H. (2011). Epidemiology of food allergy. Journal of Allergy and Clinical Immunology 127(3): 594-602. 10 Carrard, A., D. Rizzuti, et al. (2015). Update on food allergy. Allergy. 70: 1511-1520. 11 Chin, S. and B. P. Vickery. (2012). Pathogenesis of food allergy in the pediatric patient. Curr Allergy Asthma Rep 12(6): 621-9. 12 Allen, K. J. and J. J. Koplin. (2015). Why Does Australia Appear to Have the Highest Rates of Food Allergy? Pediatr Clin North Am 62(6): 1441-51. 7

[FR Doc. 2016-06666 Filed: 3/28/2016 8:45 am; Publication Date: 3/29/2016] 8